Colorectal Cancer
Exact Sciences Shares Rise on Unexpected Reimbursement Rate From CMS for Next-Gen Cologuard Test
The next-generation version of the Cologuard test received FDA approval last month and is expected to launch next year.
Top Five Articles on 360Dx Last Week: Test for COPD Flare-Ups; Clinical Use of Wearable Techs; More
Last week, readers were most interested in a story about the development of an AI-based method to predict COPD flare-ups before symptoms appear.
In an indirect comparison study by researchers in Germany, a fecal immunochemical test showed similar sensitivity and specificity as Exact Sciences' Cologuard Plus test.
MetaSight Diagnostics Closes $8M Oversubscribed Series A Round
The company uses mass spectrometry technologies to develop liquid biopsy diagnostics for a variety of diseases, including colorectal cancer.
Mainz Biomed, Thermo Fisher Scientific to Develop Colorectal Cancer Screening Test
The collaboration will enable Mainz Biomed to harness Thermo Fisher’s resources to develop a new version of its mRNA-based colorectal cancer screening test.